ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Richard Wood, ICRF, Accepts Appointment At Pittsburgh.

March 2, 2001

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

NCI Study Tests Method For Biomarker Validation

July 24, 2009

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987